US$ 28.93
glp 1 agonists examples Market Overview: GLP-1 and the Obesity Market | Blog Mapping the effectiveness and risks
Description
Why Choose GLP 1 Capsules

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Regularly reviewing your Medicare coverage is essential to ensure your plan meets your evolving health needs.

However, a large proportion of people with T2D are not able to achieve glycaemic goals because of clinical inertia
